Related content

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome

By Wu Jie   Zhu Yiqing   Jiang Yunfei   Cao Yaoping  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects

By Nardo L. G.   Rai R.  

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?

By Gennarelli G  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 535-541

Oxford University Press

Access to resources Recommend Favorite

Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics

By Ates Seda   Sevket Osman   Sudolmus Sinem   Dane Banu   Ozkal Fulya   Uysal Omer   Dansuk Ramazan  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 931-935

Informa Healthcare

Access to resources Recommend Favorite

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial

By Fux Otta CarolinaFux   Wior Myriam   Iraci Gabriel S.   Kaplan Raquel   Torres Diana   Gaido María Isabel   Wyse Eduardo P.  

Gynecological Endocrinology, Vol. 26, Iss. 3, 2010-03 ,pp. : 173-178

Informa Healthcare

Access to resources Recommend Favorite